Germany· DE-A57-af423a482742b517

Renoscint Mag3

A betiatide product containing betiatide, registered in Germany by Medi-Radiopharma Kft.. The same ATC class is registered in 3 of our 19 countries.

ATC Betiatide

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedRenoscint Mag3ATCBetiatideREGISTER NO.DE-A57-af423a482742b5…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Betiatide is registered in 3 of 19 countries.

Countries holding a registration under ATC Betiatide (betiatide), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 1 of them publish a price we can compare per daily dose

Betiatide · ATC Betiatide

3 / 19 countries

  • Germany
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

EMA Article 57 (European Union)
Active substance
Betiatide
Manufacturer
Medi-Radiopharma Kft.
Country
Germany (DE)
ATC code
Betiatide
ATC class
Betiatide
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Betiatide in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All betiatide products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Renoscint Mag3, Technescan Mag3
  • Belgium · Technescan Mag3
  • Czechia · Renoscint Mag3, Technescan Mag3
  • Denmark · Renoscint Mag3, Technescan Mag3
  • Spain · Mag3 Radiopharmacy, Mag3 Technescan
  • Finland · Technescan Mag3
  • France · Technescan Mag 3
  • United Kingdom (Northern Ireland) · Renoscan Mag3, Technescan Mag3
  • Greece · Technescan Mag3
  • Hungary · Renoscint Mag3, Technescan Mag3
  • Ireland · Technescan Mag3
  • Italy · Medirenoscint, Technescan Mag3
  • Malta · Renoscint Mag3
  • Netherlands · Technescan Mag3
  • Norway · Technescan Mag3
  • Poland · Renoscint Mag3
  • Portugal · Technescan Mag3
  • Sweden · Technescan Mag3
  • Slovakia · Technescan Mag3

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d29ee8fe-e252-433b-8371-ebdb86542f77
GET /v1/drugs/d29ee8fe-e252-433b-8371-ebdb86542f77?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Intravenous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Betiatide",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about betiatide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.